Premium
Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non‐alcoholic fatty liver disease
Author(s) -
Yoneda Masato,
Hotta Kikuko,
Nozaki Yuichi,
Endo Hiroki,
Tomeno Wataru,
Watanabe Seitaro,
Hosono Kunihiro,
Mawatari Hironori,
Iida Hiroshi,
Fujita Koji,
Takahashi Hirokazu,
Kirikoshi Hiroyuki,
Kobayashi Noritoshi,
Inamori Masahiko,
Kubota Kensuke,
Shimamura Takeshi,
Saito Satoru,
Maeyama Shiro,
Wada Koichiro,
Nakajima Atsushi
Publication year - 2009
Publication title -
hepatology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.123
H-Index - 75
eISSN - 1872-034X
pISSN - 1386-6346
DOI - 10.1111/j.1872-034x.2009.00539.x
Subject(s) - fatty liver , steatohepatitis , single nucleotide polymorphism , medicine , snp , odds ratio , gastroenterology , liver biopsy , allele , genotype , steatosis , nitric oxide synthase , nitric oxide , endocrinology , biology , disease , biopsy , genetics , gene
Aim: Genetic factors as well as environmental factors play an important role in the development of non‐alcoholic fatty liver disease (NAFLD). Recently, inducible nitric oxide synthase (iNOS) was significantly higher in the severest form of non‐alcoholic steatohepatitis (NASH), and nitric oxide (NO) has been determined to play an important role in the process of fibrosis in NASH. In this study, we investigated iNOS gene polymorphisms for associations with NAFLD. Methods: A total of 115 NAFLD patients, consisting of 65 patients with NASH and 50 patients with simple steatosis, in whom a positive diagnosis had been made by liver biopsy, and 435 healthy control subjects, were recruited into this study. Results: We investigated 10 single nucleotide polymorphisms (SNP) of the iNOS gene, one of which, rs1060822, had the lowest P ‐value in the allele frequency model ( P = 0.00078) with an odds ratio (95% confidence interval) of 0.49 (0.32–0.75). Four SNP, rs2297510, rs2297511, rs2797512 and rs1060822, were significantly associated with NAFLD, even when the most conservative Bonferroni's correction was applied. Linkage disequilibrium analysis revealed that SNP rs1060822 and three other SNP, rs2297510, rs2297511 and rs2797512, were in the same block. We also investigated associations between rs1060822 genotypes and the fibrosis index, and the results of the analysis revealed an additive increase in the fibrosis index and intrahepatic iNOS mRNA expression in the patients with the T allele of rs1060822. Conclusion: This is the first study to identify genetic variations in iNOS that may influence the risk of NAFLD and liver fibrosis in NAFLD.